Boston Scientific to Spend $40 Million on Stent Post-Op Campaign
Boston Scientific has dedicated $40 million to a program educating drug-eluting stent patients about the importance of taking blood thinners after their operations, the Boston Globe reports. The company has produced kits that will go to about 700,000 patients a year.
April 2, 2007
It will also push to have patients counseled about taking blood thinners before they are discharged from the hospital.All this is coming after the controversy over whether drug-eluting stents are more likely to cause blood clots than their bare-metal counterparts. And the program is unveiled a week after two studies questioned whether stents should be used in non-emergency cases at all. Is this good medicine? Yes. Does the timing make the company look like it's on the defensive? Yes again.
You May Also Like